Back to results
RecruitingPhase 1Phase 2

Mechanisms of Semaglutide Therapy in Heart Failure Patients

NCT06541509

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Greenstone Biosciences

Palo Alto, California, United States

+2 additional locations

Contact

Bojan Vrtovec, MD, PhD

+3861 522 1157bojan.vrtovec@kclj.si
View on ClinicalTrials.gov
Mechanisms of Semaglutide Therapy in Heart Failure Patients — TrialFind